nodes	percent_of_prediction	percent_of_DWPC	metapath
Fospropofol—ALB—type 2 diabetes mellitus	0.208	1	CbGaD
Fospropofol—ALB—Gliclazide—type 2 diabetes mellitus	0.0947	0.204	CbGbCtD
Fospropofol—ALB—Repaglinide—type 2 diabetes mellitus	0.0891	0.192	CbGbCtD
Fospropofol—ALB—Rosiglitazone—type 2 diabetes mellitus	0.0743	0.16	CbGbCtD
Fospropofol—ALB—Valsartan—type 2 diabetes mellitus	0.0657	0.142	CbGbCtD
Fospropofol—ALB—Nateglinide—type 2 diabetes mellitus	0.061	0.132	CbGbCtD
Fospropofol—ALB—Glyburide—type 2 diabetes mellitus	0.0412	0.0889	CbGbCtD
Fospropofol—ALB—Losartan—type 2 diabetes mellitus	0.0377	0.0813	CbGbCtD
Fospropofol—Tingling sensation—Bromocriptine—type 2 diabetes mellitus	0.00318	0.0195	CcSEcCtD
Fospropofol—Hepatic failure—Rosiglitazone—type 2 diabetes mellitus	0.0028	0.0172	CcSEcCtD
Fospropofol—Ventricular tachycardia—Bromocriptine—type 2 diabetes mellitus	0.00255	0.0157	CcSEcCtD
Fospropofol—Hepatic failure—Pioglitazone—type 2 diabetes mellitus	0.00235	0.0144	CcSEcCtD
Fospropofol—Hepatic failure—Glimepiride—type 2 diabetes mellitus	0.00229	0.014	CcSEcCtD
Fospropofol—Propofol—CYP2E1—type 2 diabetes mellitus	0.00208	0.319	CrCbGaD
Fospropofol—Mediastinal disorder—Linagliptin—type 2 diabetes mellitus	0.00205	0.0126	CcSEcCtD
Fospropofol—Angiopathy—Acarbose—type 2 diabetes mellitus	0.002	0.0123	CcSEcCtD
Fospropofol—Propofol—CYP1A2—type 2 diabetes mellitus	0.00198	0.304	CrCbGaD
Fospropofol—Stinging—Losartan—type 2 diabetes mellitus	0.00192	0.0118	CcSEcCtD
Fospropofol—Hepatic failure—Glyburide—type 2 diabetes mellitus	0.00189	0.0116	CcSEcCtD
Fospropofol—Cough—Linagliptin—type 2 diabetes mellitus	0.00173	0.0106	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Miglitol—type 2 diabetes mellitus	0.00172	0.0106	CcSEcCtD
Fospropofol—Hepatic failure—Gliclazide—type 2 diabetes mellitus	0.00169	0.0104	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Linagliptin—type 2 diabetes mellitus	0.00167	0.0103	CcSEcCtD
Fospropofol—Cough—Nateglinide—type 2 diabetes mellitus	0.00162	0.00992	CcSEcCtD
Fospropofol—Skin disorder—Linagliptin—type 2 diabetes mellitus	0.00157	0.00962	CcSEcCtD
Fospropofol—Ventricular tachycardia—Losartan—type 2 diabetes mellitus	0.00156	0.00956	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Tolbutamide—type 2 diabetes mellitus	0.00155	0.0095	CcSEcCtD
Fospropofol—Hepatic failure—Orlistat—type 2 diabetes mellitus	0.00154	0.00944	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Chlorpropamide—type 2 diabetes mellitus	0.00141	0.00864	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Tolazamide—type 2 diabetes mellitus	0.00141	0.00864	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Linagliptin—type 2 diabetes mellitus	0.00139	0.00855	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Repaglinide—type 2 diabetes mellitus	0.00136	0.00832	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Acarbose—type 2 diabetes mellitus	0.00135	0.0083	CcSEcCtD
Fospropofol—Mediastinal disorder—Pioglitazone—type 2 diabetes mellitus	0.00132	0.00807	CcSEcCtD
Fospropofol—Propofol—CYP3A4—type 2 diabetes mellitus	0.00131	0.201	CrCbGaD
Fospropofol—Gastrointestinal disorder—Nateglinide—type 2 diabetes mellitus	0.00131	0.00801	CcSEcCtD
Fospropofol—Angiopathy—Sitagliptin—type 2 diabetes mellitus	0.00129	0.00789	CcSEcCtD
Fospropofol—Mediastinal disorder—Sitagliptin—type 2 diabetes mellitus	0.00128	0.00784	CcSEcCtD
Fospropofol—Skin disorder—Repaglinide—type 2 diabetes mellitus	0.00127	0.0078	CcSEcCtD
Fospropofol—Pruritus—Tolbutamide—type 2 diabetes mellitus	0.00127	0.00779	CcSEcCtD
Fospropofol—Nervous system disorder—Rosiglitazone—type 2 diabetes mellitus	0.00121	0.00744	CcSEcCtD
Fospropofol—Nausea—Miglitol—type 2 diabetes mellitus	0.00118	0.00727	CcSEcCtD
Fospropofol—Paraesthesia—Repaglinide—type 2 diabetes mellitus	0.00118	0.00721	CcSEcCtD
Fospropofol—Angiopathy—Bromocriptine—type 2 diabetes mellitus	0.00116	0.00714	CcSEcCtD
Fospropofol—Mediastinal disorder—Bromocriptine—type 2 diabetes mellitus	0.00116	0.00709	CcSEcCtD
Fospropofol—Pruritus—Chlorpropamide—type 2 diabetes mellitus	0.00115	0.00708	CcSEcCtD
Fospropofol—Pruritus—Tolazamide—type 2 diabetes mellitus	0.00115	0.00708	CcSEcCtD
Fospropofol—Propofol—ALB—type 2 diabetes mellitus	0.00114	0.175	CrCbGaD
Fospropofol—Gastrointestinal disorder—Repaglinide—type 2 diabetes mellitus	0.00113	0.00693	CcSEcCtD
Fospropofol—Headache—Tolbutamide—type 2 diabetes mellitus	0.00112	0.00689	CcSEcCtD
Fospropofol—Hepatic failure—Ramipril—type 2 diabetes mellitus	0.00108	0.00662	CcSEcCtD
Fospropofol—Cough—Sitagliptin—type 2 diabetes mellitus	0.00108	0.00661	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Pioglitazone—type 2 diabetes mellitus	0.00107	0.00659	CcSEcCtD
Fospropofol—Pruritus—Nateglinide—type 2 diabetes mellitus	0.00107	0.00656	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Rosiglitazone—type 2 diabetes mellitus	0.00107	0.00655	CcSEcCtD
Fospropofol—Nausea—Tolbutamide—type 2 diabetes mellitus	0.00107	0.00654	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Sitagliptin—type 2 diabetes mellitus	0.00104	0.0064	CcSEcCtD
Fospropofol—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.00104	0.00637	CcSEcCtD
Fospropofol—Headache—Tolazamide—type 2 diabetes mellitus	0.00102	0.00627	CcSEcCtD
Fospropofol—Headache—Chlorpropamide—type 2 diabetes mellitus	0.00102	0.00627	CcSEcCtD
Fospropofol—Nervous system disorder—Pioglitazone—type 2 diabetes mellitus	0.00102	0.00624	CcSEcCtD
Fospropofol—Headache—Linagliptin—type 2 diabetes mellitus	0.00101	0.00621	CcSEcCtD
Fospropofol—Skin disorder—Pioglitazone—type 2 diabetes mellitus	0.00101	0.00618	CcSEcCtD
Fospropofol—Vomiting—Acarbose—type 2 diabetes mellitus	0.000997	0.00612	CcSEcCtD
Fospropofol—Nervous system disorder—Sitagliptin—type 2 diabetes mellitus	0.000988	0.00606	CcSEcCtD
Fospropofol—Skin disorder—Sitagliptin—type 2 diabetes mellitus	0.000978	0.006	CcSEcCtD
Fospropofol—Paraesthesia—Glipizide—type 2 diabetes mellitus	0.000972	0.00596	CcSEcCtD
Fospropofol—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000969	0.00595	CcSEcCtD
Fospropofol—Nausea—Tolazamide—type 2 diabetes mellitus	0.000969	0.00595	CcSEcCtD
Fospropofol—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000961	0.0059	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Bromocriptine—type 2 diabetes mellitus	0.000944	0.00579	CcSEcCtD
Fospropofol—Hypotension—Glimepiride—type 2 diabetes mellitus	0.000944	0.00579	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Glipizide—type 2 diabetes mellitus	0.000935	0.00573	CcSEcCtD
Fospropofol—Nausea—Acarbose—type 2 diabetes mellitus	0.000931	0.00571	CcSEcCtD
Fospropofol—Pain—Glipizide—type 2 diabetes mellitus	0.000926	0.00568	CcSEcCtD
Fospropofol—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000926	0.00568	CcSEcCtD
Fospropofol—Paraesthesia—Glimepiride—type 2 diabetes mellitus	0.000907	0.00557	CcSEcCtD
Fospropofol—Nausea—Nateglinide—type 2 diabetes mellitus	0.000898	0.00551	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.000895	0.00549	CcSEcCtD
Fospropofol—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.000894	0.00548	CcSEcCtD
Fospropofol—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.000885	0.00543	CcSEcCtD
Fospropofol—Angiopathy—Valsartan—type 2 diabetes mellitus	0.000878	0.00539	CcSEcCtD
Fospropofol—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000875	0.00537	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000872	0.00535	CcSEcCtD
Fospropofol—Mediastinal disorder—Valsartan—type 2 diabetes mellitus	0.000872	0.00535	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000869	0.00533	CcSEcCtD
Fospropofol—Mediastinal disorder—Orlistat—type 2 diabetes mellitus	0.000862	0.00529	CcSEcCtD
Fospropofol—Pain—Sitagliptin—type 2 diabetes mellitus	0.000861	0.00528	CcSEcCtD
Fospropofol—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000852	0.00523	CcSEcCtD
Fospropofol—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000832	0.0051	CcSEcCtD
Fospropofol—Headache—Repaglinide—type 2 diabetes mellitus	0.00082	0.00503	CcSEcCtD
Fospropofol—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.000818	0.00502	CcSEcCtD
Fospropofol—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000817	0.00501	CcSEcCtD
Fospropofol—Cough—Gliclazide—type 2 diabetes mellitus	0.0008	0.00491	CcSEcCtD
Fospropofol—Angiopathy—Metformin—type 2 diabetes mellitus	0.000799	0.0049	CcSEcCtD
Fospropofol—Mediastinal disorder—Metformin—type 2 diabetes mellitus	0.000794	0.00487	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000787	0.00483	CcSEcCtD
Fospropofol—Hypotension—Glyburide—type 2 diabetes mellitus	0.000779	0.00478	CcSEcCtD
Fospropofol—Nausea—Repaglinide—type 2 diabetes mellitus	0.000777	0.00477	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000775	0.00476	CcSEcCtD
Fospropofol—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000775	0.00475	CcSEcCtD
Fospropofol—Pruritus—Glipizide—type 2 diabetes mellitus	0.000766	0.0047	CcSEcCtD
Fospropofol—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.000754	0.00463	CcSEcCtD
Fospropofol—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.000749	0.0046	CcSEcCtD
Fospropofol—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000748	0.00459	CcSEcCtD
Fospropofol—Cough—Valsartan—type 2 diabetes mellitus	0.000735	0.00451	CcSEcCtD
Fospropofol—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000735	0.00451	CcSEcCtD
Fospropofol—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000734	0.0045	CcSEcCtD
Fospropofol—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000727	0.00446	CcSEcCtD
Fospropofol—Cough—Orlistat—type 2 diabetes mellitus	0.000726	0.00446	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000719	0.00441	CcSEcCtD
Fospropofol—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000715	0.00439	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000712	0.00437	CcSEcCtD
Fospropofol—Angiopathy—Losartan—type 2 diabetes mellitus	0.00071	0.00436	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000704	0.00432	CcSEcCtD
Fospropofol—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000699	0.00429	CcSEcCtD
Fospropofol—Vomiting—Glipizide—type 2 diabetes mellitus	0.000688	0.00422	CcSEcCtD
Fospropofol—Headache—Glipizide—type 2 diabetes mellitus	0.000678	0.00416	CcSEcCtD
Fospropofol—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000674	0.00414	CcSEcCtD
Fospropofol—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000672	0.00412	CcSEcCtD
Fospropofol—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000668	0.0041	CcSEcCtD
Fospropofol—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000666	0.00409	CcSEcCtD
Fospropofol—Skin disorder—Orlistat—type 2 diabetes mellitus	0.00066	0.00405	CcSEcCtD
Fospropofol—Headache—Pioglitazone—type 2 diabetes mellitus	0.00065	0.00399	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000648	0.00398	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000646	0.00396	CcSEcCtD
Fospropofol—Nausea—Glipizide—type 2 diabetes mellitus	0.000643	0.00395	CcSEcCtD
Fospropofol—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000642	0.00394	CcSEcCtD
Fospropofol—Hypotension—Valsartan—type 2 diabetes mellitus	0.000642	0.00394	CcSEcCtD
Fospropofol—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00064	0.00393	CcSEcCtD
Fospropofol—Pain—Gliclazide—type 2 diabetes mellitus	0.00064	0.00393	CcSEcCtD
Fospropofol—Headache—Glimepiride—type 2 diabetes mellitus	0.000633	0.00388	CcSEcCtD
Fospropofol—Cough—Irbesartan—type 2 diabetes mellitus	0.000632	0.00388	CcSEcCtD
Fospropofol—Headache—Sitagliptin—type 2 diabetes mellitus	0.000631	0.00387	CcSEcCtD
Fospropofol—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000617	0.00379	CcSEcCtD
Fospropofol—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000614	0.00377	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000612	0.00375	CcSEcCtD
Fospropofol—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.00061	0.00374	CcSEcCtD
Fospropofol—Skin disorder—Metformin—type 2 diabetes mellitus	0.000608	0.00373	CcSEcCtD
Fospropofol—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000605	0.00371	CcSEcCtD
Fospropofol—Nausea—Glimepiride—type 2 diabetes mellitus	0.0006	0.00368	CcSEcCtD
Fospropofol—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000598	0.00367	CcSEcCtD
Fospropofol—Cough—Losartan—type 2 diabetes mellitus	0.000594	0.00365	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000593	0.00364	CcSEcCtD
Fospropofol—Pruritus—Glyburide—type 2 diabetes mellitus	0.000589	0.00362	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000586	0.0036	CcSEcCtD
Fospropofol—Hypotension—Metformin—type 2 diabetes mellitus	0.000585	0.00359	CcSEcCtD
Fospropofol—Pain—Orlistat—type 2 diabetes mellitus	0.000581	0.00356	CcSEcCtD
Fospropofol—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00058	0.00356	CcSEcCtD
Fospropofol—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000579	0.00355	CcSEcCtD
Fospropofol—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000574	0.00352	CcSEcCtD
Fospropofol—Headache—Bromocriptine—type 2 diabetes mellitus	0.000571	0.0035	CcSEcCtD
Fospropofol—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000562	0.00345	CcSEcCtD
Fospropofol—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000552	0.00339	CcSEcCtD
Fospropofol—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000545	0.00334	CcSEcCtD
Fospropofol—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000541	0.00332	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.00054	0.00332	CcSEcCtD
Fospropofol—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.00053	0.00325	CcSEcCtD
Fospropofol—Vomiting—Glyburide—type 2 diabetes mellitus	0.00053	0.00325	CcSEcCtD
Fospropofol—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000529	0.00325	CcSEcCtD
Fospropofol—Headache—Glyburide—type 2 diabetes mellitus	0.000522	0.0032	CcSEcCtD
Fospropofol—Hypotension—Losartan—type 2 diabetes mellitus	0.000519	0.00319	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.00051	0.00313	CcSEcCtD
Fospropofol—Cough—Ramipril—type 2 diabetes mellitus	0.00051	0.00313	CcSEcCtD
Fospropofol—Pain—Irbesartan—type 2 diabetes mellitus	0.000505	0.0031	CcSEcCtD
Fospropofol—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000499	0.00306	CcSEcCtD
Fospropofol—Nausea—Glyburide—type 2 diabetes mellitus	0.000495	0.00304	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000494	0.00303	CcSEcCtD
Fospropofol—Pruritus—Valsartan—type 2 diabetes mellitus	0.000486	0.00298	CcSEcCtD
Fospropofol—Pruritus—Orlistat—type 2 diabetes mellitus	0.000481	0.00295	CcSEcCtD
Fospropofol—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000476	0.00292	CcSEcCtD
Fospropofol—Pain—Losartan—type 2 diabetes mellitus	0.000475	0.00292	CcSEcCtD
Fospropofol—Headache—Gliclazide—type 2 diabetes mellitus	0.000469	0.00288	CcSEcCtD
Fospropofol—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000467	0.00287	CcSEcCtD
Fospropofol—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000463	0.00284	CcSEcCtD
Fospropofol—Hypotension—Ramipril—type 2 diabetes mellitus	0.000445	0.00273	CcSEcCtD
Fospropofol—Nausea—Gliclazide—type 2 diabetes mellitus	0.000444	0.00273	CcSEcCtD
Fospropofol—Pruritus—Metformin—type 2 diabetes mellitus	0.000443	0.00272	CcSEcCtD
Fospropofol—Vomiting—Valsartan—type 2 diabetes mellitus	0.000437	0.00268	CcSEcCtD
Fospropofol—Vomiting—Orlistat—type 2 diabetes mellitus	0.000432	0.00265	CcSEcCtD
Fospropofol—Headache—Valsartan—type 2 diabetes mellitus	0.000431	0.00264	CcSEcCtD
Fospropofol—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000428	0.00263	CcSEcCtD
Fospropofol—Headache—Orlistat—type 2 diabetes mellitus	0.000426	0.00261	CcSEcCtD
Fospropofol—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000418	0.00256	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000412	0.00253	CcSEcCtD
Fospropofol—Nausea—Valsartan—type 2 diabetes mellitus	0.000408	0.00251	CcSEcCtD
Fospropofol—Nausea—Orlistat—type 2 diabetes mellitus	0.000403	0.00248	CcSEcCtD
Fospropofol—Vomiting—Metformin—type 2 diabetes mellitus	0.000398	0.00244	CcSEcCtD
Fospropofol—Pruritus—Losartan—type 2 diabetes mellitus	0.000393	0.00241	CcSEcCtD
Fospropofol—Headache—Metformin—type 2 diabetes mellitus	0.000392	0.00241	CcSEcCtD
Fospropofol—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000376	0.0023	CcSEcCtD
Fospropofol—Nausea—Metformin—type 2 diabetes mellitus	0.000372	0.00228	CcSEcCtD
Fospropofol—Headache—Irbesartan—type 2 diabetes mellitus	0.00037	0.00227	CcSEcCtD
Fospropofol—Vomiting—Losartan—type 2 diabetes mellitus	0.000353	0.00217	CcSEcCtD
Fospropofol—Nausea—Irbesartan—type 2 diabetes mellitus	0.000351	0.00215	CcSEcCtD
Fospropofol—Headache—Losartan—type 2 diabetes mellitus	0.000348	0.00214	CcSEcCtD
Fospropofol—Pruritus—Ramipril—type 2 diabetes mellitus	0.000337	0.00207	CcSEcCtD
Fospropofol—Nausea—Losartan—type 2 diabetes mellitus	0.00033	0.00203	CcSEcCtD
Fospropofol—Vomiting—Ramipril—type 2 diabetes mellitus	0.000303	0.00186	CcSEcCtD
Fospropofol—Headache—Ramipril—type 2 diabetes mellitus	0.000299	0.00183	CcSEcCtD
Fospropofol—Nausea—Ramipril—type 2 diabetes mellitus	0.000283	0.00174	CcSEcCtD
Fospropofol—GABRB2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	3.83e-05	0.000242	CbGpPWpGaD
Fospropofol—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—type 2 diabetes mellitus	3.81e-05	0.000241	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	3.79e-05	0.000239	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	3.79e-05	0.000239	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—NFKB1—type 2 diabetes mellitus	3.78e-05	0.000239	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	3.77e-05	0.000238	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	3.76e-05	0.000237	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	3.76e-05	0.000237	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	3.72e-05	0.000235	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	3.71e-05	0.000235	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	3.71e-05	0.000234	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	3.7e-05	0.000234	CbGpPWpGaD
Fospropofol—ALB—Platelet degranulation—VEGFA—type 2 diabetes mellitus	3.7e-05	0.000234	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—TNF—type 2 diabetes mellitus	3.7e-05	0.000234	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	3.69e-05	0.000233	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	3.69e-05	0.000233	CbGpPWpGaD
Fospropofol—ALB—Vitamin B12 Metabolism—IL6—type 2 diabetes mellitus	3.67e-05	0.000232	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	3.66e-05	0.000231	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	3.66e-05	0.000231	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	3.64e-05	0.00023	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—THBD—type 2 diabetes mellitus	3.63e-05	0.000229	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	3.63e-05	0.000229	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	3.62e-05	0.000229	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	3.6e-05	0.000228	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	3.6e-05	0.000228	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	3.6e-05	0.000227	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	3.59e-05	0.000227	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	3.57e-05	0.000226	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	3.55e-05	0.000225	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	3.54e-05	0.000223	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	3.53e-05	0.000223	CbGpPWpGaD
Fospropofol—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—type 2 diabetes mellitus	3.53e-05	0.000223	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	3.51e-05	0.000222	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	3.51e-05	0.000222	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	3.51e-05	0.000221	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	3.48e-05	0.00022	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	3.47e-05	0.000219	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	3.46e-05	0.000219	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	3.46e-05	0.000219	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	3.46e-05	0.000218	CbGpPWpGaD
Fospropofol—ALB—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	3.45e-05	0.000218	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	3.45e-05	0.000218	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—CD36—type 2 diabetes mellitus	3.45e-05	0.000218	CbGpPWpGaD
Fospropofol—ALB—Metabolism—BHMT—type 2 diabetes mellitus	3.44e-05	0.000218	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	3.43e-05	0.000217	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	3.42e-05	0.000216	CbGpPWpGaD
Fospropofol—ALB—Platelet degranulation—TGFB1—type 2 diabetes mellitus	3.4e-05	0.000215	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	3.39e-05	0.000214	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	3.36e-05	0.000213	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	3.34e-05	0.000211	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	3.3e-05	0.000209	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	3.25e-05	0.000205	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	3.25e-05	0.000205	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	3.25e-05	0.000205	CbGpPWpGaD
Fospropofol—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—type 2 diabetes mellitus	3.24e-05	0.000204	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	3.23e-05	0.000204	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	3.2e-05	0.000202	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	3.2e-05	0.000202	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	3.17e-05	0.0002	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	3.12e-05	0.000197	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	3.11e-05	0.000196	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	3.09e-05	0.000195	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—ATP2A2—type 2 diabetes mellitus	3.06e-05	0.000194	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	3.06e-05	0.000194	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—CALM1—type 2 diabetes mellitus	3.05e-05	0.000193	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	3.04e-05	0.000192	CbGpPWpGaD
Fospropofol—ALB—Metabolism—AANAT—type 2 diabetes mellitus	3.01e-05	0.00019	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PTGDS—type 2 diabetes mellitus	3.01e-05	0.00019	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—APOA1—type 2 diabetes mellitus	3.01e-05	0.00019	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—AKT1—type 2 diabetes mellitus	3e-05	0.00019	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—IL6—type 2 diabetes mellitus	2.99e-05	0.000189	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.98e-05	0.000188	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—TRPC6—type 2 diabetes mellitus	2.97e-05	0.000188	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2.96e-05	0.000187	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—TNF—type 2 diabetes mellitus	2.94e-05	0.000186	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.93e-05	0.000185	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.93e-05	0.000185	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—F7—type 2 diabetes mellitus	2.92e-05	0.000185	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.91e-05	0.000184	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—PRKCB—type 2 diabetes mellitus	2.87e-05	0.000181	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	2.86e-05	0.000181	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.86e-05	0.000181	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GPD2—type 2 diabetes mellitus	2.85e-05	0.00018	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CDO1—type 2 diabetes mellitus	2.85e-05	0.00018	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.85e-05	0.00018	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.8e-05	0.000177	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	2.79e-05	0.000176	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	2.78e-05	0.000176	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	2.77e-05	0.000175	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.77e-05	0.000175	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.76e-05	0.000174	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.75e-05	0.000174	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.73e-05	0.000172	CbGpPWpGaD
Fospropofol—ALB—Metabolism—AK1—type 2 diabetes mellitus	2.72e-05	0.000172	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.72e-05	0.000172	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	2.69e-05	0.00017	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.68e-05	0.000169	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	2.65e-05	0.000168	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	2.65e-05	0.000168	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	2.62e-05	0.000166	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—ADRA2A—type 2 diabetes mellitus	2.62e-05	0.000165	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—TIMP1—type 2 diabetes mellitus	2.61e-05	0.000165	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PLAT—type 2 diabetes mellitus	2.61e-05	0.000165	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	2.59e-05	0.000164	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	2.57e-05	0.000163	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.57e-05	0.000162	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	2.56e-05	0.000162	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.54e-05	0.00016	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SLC5A4—type 2 diabetes mellitus	2.51e-05	0.000159	CbGpPWpGaD
Fospropofol—ALB—Metabolism—MAT1A—type 2 diabetes mellitus	2.51e-05	0.000159	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—IGF1—type 2 diabetes mellitus	2.51e-05	0.000159	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—AKT2—type 2 diabetes mellitus	2.51e-05	0.000159	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	2.5e-05	0.000158	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.5e-05	0.000158	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	2.46e-05	0.000155	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—NOS1—type 2 diabetes mellitus	2.45e-05	0.000155	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	2.43e-05	0.000154	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PPP1R3C—type 2 diabetes mellitus	2.43e-05	0.000153	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ND1—type 2 diabetes mellitus	2.43e-05	0.000153	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ENPP1—type 2 diabetes mellitus	2.43e-05	0.000153	CbGpPWpGaD
Fospropofol—ALB—Metabolism—HBA2—type 2 diabetes mellitus	2.43e-05	0.000153	CbGpPWpGaD
Fospropofol—ALB—Metabolism—G6PC—type 2 diabetes mellitus	2.43e-05	0.000153	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—SERPINE1—type 2 diabetes mellitus	2.39e-05	0.000151	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PTPN1—type 2 diabetes mellitus	2.38e-05	0.000151	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—IL6—type 2 diabetes mellitus	2.37e-05	0.00015	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GCGR—type 2 diabetes mellitus	2.35e-05	0.000149	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—RASGRP1—type 2 diabetes mellitus	2.34e-05	0.000148	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.34e-05	0.000148	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.32e-05	0.000147	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—PIK3R1—type 2 diabetes mellitus	2.28e-05	0.000144	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	2.26e-05	0.000143	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.26e-05	0.000143	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	2.26e-05	0.000143	CbGpPWpGaD
Fospropofol—ALB—Metabolism—OXCT1—type 2 diabetes mellitus	2.22e-05	0.00014	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CYTB—type 2 diabetes mellitus	2.22e-05	0.00014	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.22e-05	0.00014	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.18e-05	0.000138	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SRD5A1—type 2 diabetes mellitus	2.16e-05	0.000137	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.16e-05	0.000137	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	2.15e-05	0.000136	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—SOD1—type 2 diabetes mellitus	2.12e-05	0.000134	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.12e-05	0.000134	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ACACA—type 2 diabetes mellitus	2.06e-05	0.00013	CbGpPWpGaD
Fospropofol—ALB—Metabolism—STAR—type 2 diabetes mellitus	2.06e-05	0.00013	CbGpPWpGaD
Fospropofol—ALB—Metabolism—HSD17B3—type 2 diabetes mellitus	2.06e-05	0.00013	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	2.06e-05	0.00013	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—GNB3—type 2 diabetes mellitus	2.05e-05	0.00013	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—IGF2—type 2 diabetes mellitus	2.02e-05	0.000127	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ABCC8—type 2 diabetes mellitus	1.98e-05	0.000125	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CBS—type 2 diabetes mellitus	1.98e-05	0.000125	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—APOB—type 2 diabetes mellitus	1.96e-05	0.000124	CbGpPWpGaD
Fospropofol—ALB—Metabolism—COX2—type 2 diabetes mellitus	1.9e-05	0.00012	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SLC5A2—type 2 diabetes mellitus	1.9e-05	0.00012	CbGpPWpGaD
Fospropofol—ALB—Metabolism—NCOA6—type 2 diabetes mellitus	1.87e-05	0.000118	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.87e-05	0.000118	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.86e-05	0.000117	CbGpPWpGaD
Fospropofol—ALB—Metabolism—UCP2—type 2 diabetes mellitus	1.84e-05	0.000116	CbGpPWpGaD
Fospropofol—ALB—Metabolism—UCP3—type 2 diabetes mellitus	1.84e-05	0.000116	CbGpPWpGaD
Fospropofol—ALB—Metabolism—HSD11B1—type 2 diabetes mellitus	1.84e-05	0.000116	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.78e-05	0.000113	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.78e-05	0.000112	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—CD36—type 2 diabetes mellitus	1.78e-05	0.000112	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.77e-05	0.000112	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PPP2CA—type 2 diabetes mellitus	1.75e-05	0.000111	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.75e-05	0.000111	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PCK1—type 2 diabetes mellitus	1.73e-05	0.000109	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.7e-05	0.000108	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.7e-05	0.000107	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—SRC—type 2 diabetes mellitus	1.69e-05	0.000106	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.66e-05	0.000105	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—VEGFA—type 2 diabetes mellitus	1.64e-05	0.000104	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—MMP1—type 2 diabetes mellitus	1.62e-05	0.000102	CbGpPWpGaD
Fospropofol—ALB—Metabolism—HK1—type 2 diabetes mellitus	1.62e-05	0.000102	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.62e-05	0.000102	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.58e-05	0.0001	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—CALM1—type 2 diabetes mellitus	1.57e-05	9.94e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—LPA—type 2 diabetes mellitus	1.56e-05	9.88e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—KCNJ11—type 2 diabetes mellitus	1.56e-05	9.88e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GCKR—type 2 diabetes mellitus	1.56e-05	9.88e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—HSD3B2—type 2 diabetes mellitus	1.56e-05	9.88e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—APOA1—type 2 diabetes mellitus	1.55e-05	9.79e-05	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—TGFB1—type 2 diabetes mellitus	1.51e-05	9.52e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.5e-05	9.5e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ALDOB—type 2 diabetes mellitus	1.5e-05	9.47e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PRKCB—type 2 diabetes mellitus	1.48e-05	9.34e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—NOS2—type 2 diabetes mellitus	1.46e-05	9.23e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.46e-05	9.2e-05	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.43e-05	9.03e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.43e-05	9.02e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.41e-05	8.91e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GLP1R—type 2 diabetes mellitus	1.39e-05	8.81e-05	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.34e-05	8.47e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SLC2A2—type 2 diabetes mellitus	1.3e-05	8.22e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—IGF1—type 2 diabetes mellitus	1.3e-05	8.18e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—AKT2—type 2 diabetes mellitus	1.29e-05	8.18e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—MTR—type 2 diabetes mellitus	1.27e-05	8.05e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CPT1A—type 2 diabetes mellitus	1.27e-05	8.05e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—NAMPT—type 2 diabetes mellitus	1.25e-05	7.9e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.24e-05	7.85e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—LIPC—type 2 diabetes mellitus	1.24e-05	7.85e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—HBA1—type 2 diabetes mellitus	1.24e-05	7.85e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GCK—type 2 diabetes mellitus	1.24e-05	7.85e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CYP11A1—type 2 diabetes mellitus	1.23e-05	7.8e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—SERPINE1—type 2 diabetes mellitus	1.23e-05	7.77e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SLC9A1—type 2 diabetes mellitus	1.21e-05	7.66e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CETP—type 2 diabetes mellitus	1.2e-05	7.57e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PIK3R1—type 2 diabetes mellitus	1.17e-05	7.42e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—NOS3—type 2 diabetes mellitus	1.17e-05	7.42e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PSMD6—type 2 diabetes mellitus	1.11e-05	7.04e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SNAP25—type 2 diabetes mellitus	1.11e-05	7.04e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SREBF1—type 2 diabetes mellitus	1.11e-05	7.04e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CTGF—type 2 diabetes mellitus	1.09e-05	6.91e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—HMGCR—type 2 diabetes mellitus	1.08e-05	6.85e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.07e-05	6.75e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ADRA2A—type 2 diabetes mellitus	1.06e-05	6.7e-05	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	1.05e-05	6.62e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CYP2E1—type 2 diabetes mellitus	1.02e-05	6.44e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SLC2A1—type 2 diabetes mellitus	1.01e-05	6.37e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CYP1A2—type 2 diabetes mellitus	1.01e-05	6.37e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	9.83e-06	6.21e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	9.78e-06	6.18e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GCG—type 2 diabetes mellitus	9.66e-06	6.1e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	9.66e-06	6.1e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—SRC—type 2 diabetes mellitus	8.69e-06	5.49e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	8.46e-06	5.35e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.33e-06	5.26e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GNB3—type 2 diabetes mellitus	8.33e-06	5.26e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	8.29e-06	5.24e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CAT—type 2 diabetes mellitus	8.18e-06	5.17e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—APOB—type 2 diabetes mellitus	7.94e-06	5.02e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	7.77e-06	4.91e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	7.72e-06	4.88e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—LPL—type 2 diabetes mellitus	7.58e-06	4.79e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	7.42e-06	4.69e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GPX1—type 2 diabetes mellitus	7.4e-06	4.67e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CD36—type 2 diabetes mellitus	7.2e-06	4.55e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	7.11e-06	4.49e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	6.83e-06	4.31e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PPARA—type 2 diabetes mellitus	6.7e-06	4.23e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—AGT—type 2 diabetes mellitus	6.49e-06	4.1e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CALM1—type 2 diabetes mellitus	6.38e-06	4.03e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—APOE—type 2 diabetes mellitus	6.36e-06	4.02e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—APOA1—type 2 diabetes mellitus	6.28e-06	3.97e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PPARG—type 2 diabetes mellitus	5.54e-06	3.5e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—INS—type 2 diabetes mellitus	5.43e-06	3.43e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	5.4e-06	3.41e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	4.76e-06	3.01e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—NOS3—type 2 diabetes mellitus	4.76e-06	3.01e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	4.35e-06	2.75e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—AKT1—type 2 diabetes mellitus	2.19e-06	1.38e-05	CbGpPWpGaD
